The Efficacy and Safety of Chidamide Combined With VDDT Regimen Vinorelbine Liposomal Doxorubicin Dexamethasone and Thalidomide in Relapse and Refractory Patients With Diffuse Large B Cell Lymphoma

Trial Profile

The Efficacy and Safety of Chidamide Combined With VDDT Regimen Vinorelbine Liposomal Doxorubicin Dexamethasone and Thalidomide in Relapse and Refractory Patients With Diffuse Large B Cell Lymphoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 May 2016

At a glance

  • Drugs Tucidinostat (Primary) ; Dexamethasone; Doxorubicin; Mitoxantrone; Thalidomide; Vinorelbine
  • Indications Diffuse large B cell lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 May 2016 Status changed from not yet recruiting to recruiting.
    • 13 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top